← Browse by Condition
Medical Condition
metastatic hepatocellular carcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 1
NCT06811116 Phase 1, Phase 2
Recruiting
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Enrollment
92 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT05003895 Phase 1
Recruiting
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Enrollment
38 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06600321 Phase 1
Recruiting
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Enrollment
158 pts
Location
United States, Italy...
Sponsor
Alnylam Pharmaceuticals